Johnson, G J <br/><br/>
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma.  [electronic resource] 

 -  Cancer  Oct 1983 
 - 1133-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19831001)52:7<1133::aid-cncr2820520702>3.0.co;2-m  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Bleomycin--administration & dosage<br/>Clinical Trials as Topic<br/>Cyclophosphamide--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Prednisolone<br/>Prednisone--administration & dosage<br/>Vincristine--administration & dosage